Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Campbell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pediatric Transplantation|September 24, 2005
Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidatesAndrew L Campbell, Betsy C Herold
Pediatric Transplantation|December 16, 2004
Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipientsAndrew L Campbell, Betsy C Herold
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|August 21, 2009
Novel multifunctional micro-ampoules for structuring and encapsulationAndrew L Campbell, Simeon D Stoyanov, Vesselin N Paunov
Infection Control and Hospital Epidemiology|June 28, 2003
Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospitalAndrew L Campbell, Kristina A Bryant, Beth Stover, et al.
Patient Preference and Adherence|November 26, 2009
Compliance with RSV prophylaxis: Global physicians' perspectivesKari S Anderson, Victoria M Mullally, Linda M Fredrick, et al.
Transplantation|February 16, 2006
First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantationAndrew L Campbell, Cindy L Goldberg, Margret S Magid, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Transplantation|May 9, 2009
A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipientsRebecca P Madan, Andrew L Campbell, Gail F Shust, et al.
The New England Journal of Medicine|April 15, 2014
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosisFred Poordad, Christophe Hezode, Roger Trinh, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pediatric Transplantation|September 24, 2005
Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidatesAndrew L Campbell, Betsy C Herold
Pediatric Transplantation|December 16, 2004
Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipientsAndrew L Campbell, Betsy C Herold
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|August 21, 2009
Novel multifunctional micro-ampoules for structuring and encapsulationAndrew L Campbell, Simeon D Stoyanov, Vesselin N Paunov
Infection Control and Hospital Epidemiology|June 28, 2003
Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospitalAndrew L Campbell, Kristina A Bryant, Beth Stover, et al.
Patient Preference and Adherence|November 26, 2009
Compliance with RSV prophylaxis: Global physicians' perspectivesKari S Anderson, Victoria M Mullally, Linda M Fredrick, et al.
Transplantation|February 16, 2006
First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantationAndrew L Campbell, Cindy L Goldberg, Margret S Magid, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Transplantation|May 9, 2009
A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipientsRebecca P Madan, Andrew L Campbell, Gail F Shust, et al.
The New England Journal of Medicine|April 15, 2014
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosisFred Poordad, Christophe Hezode, Roger Trinh, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
Pageof 1